Endothelial dysfunction: clinical strategies for treating oxidant stress
- 31 August 2003
- journal article
- review article
- Published by Elsevier in American Heart Journal
- Vol. 146 (2) , 218-226
- https://doi.org/10.1016/s0002-8703(02)94796-4
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Mechanism of NADPH Oxidase Activation by the Rac/Rho-GDI ComplexBiochemistry, 2001
- HMG-CoA Reductase Inhibitors Improve Endothelial Dysfunction in Normocholesterolemic Hypertension via Reduced Production of Reactive Oxygen SpeciesHypertension, 2001
- Tissue Angiotensin and Pathobiology of Vascular DiseaseHypertension, 2001
- Endothelial Dysfunction and Xanthine Oxidoreductase Activity in Rats With Human Renin and Angiotensinogen GenesHypertension, 2001
- Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal WomenJAMA, 1998
- Xanthine Oxidase Inhibition With Oxypurinol Improves Endothelial Vasodilator Function in Hypercholesterolemic but Not in Hypertensive PatientsHypertension, 1997
- Oral l-arginine improves endothelium-dependent dilatation and reduces monocyte adhesion to endothelial cells in young men with coronary artery diseaseAtherosclerosis, 1997
- Angiotensin II-mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation. Contribution to alterations of vasomotor tone.Journal of Clinical Investigation, 1996
- Vitamin C improves endothelium-dependent vasodilation in patients with non-insulin-dependent diabetes mellitus.Journal of Clinical Investigation, 1996
- Effects of vitamin E on endothelial function in men after myocardial infarctionThe American Journal of Cardiology, 1995